MBOT

Latest SEC Filings & News for MBOT

5 most recent filings and news items mentioning MBOT. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/MBOT/news?limit=20"

Pull MBOT filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Microbot's LIBERTY system gains first adoption in Pennsylvania.

Microbot Medical's LIBERTY system secured its first adoption in Pennsylvania, expanding its footprint across seven U.S. states. This milestone by a leading academic health system bolsters commercial confidence, supporting plans to expand into the U.S. West Coast.

View filing at SEC.gov →

Microbot Medical partners with Lovell Government Services to access 2,000+ federal healthcare facilities

Microbot Medical's LIBERTY Endovascular Robotic System will be added to Lovell Government Services' Federal Supply Schedule contract, enabling sales across Veterans Health Administration, Military Health System, and Indian Health Service facilities. The partnership expands the co

View filing at SEC.gov →

Michigan health system becomes first Midwest adopter of LIBERTY robotic system

Microbot Medical announced a major Michigan healthcare system adopted its LIBERTY Endovascular Robotic System, marking continued expansion into new U.S. regions following North Carolina adoption. The growth reflects increasing demand for robotic solutions in peripheral endovascul

View filing at SEC.gov →

Microbot Medical secures first North Carolina healthcare system for LIBERTY robotic system

Microbot Medical announced adoption of its LIBERTY Endovascular Robotic System by a leading academic healthcare network in North Carolina, marking expansion into the South-Atlantic region. The company continues geographic penetration following full market release, demonstrating c

View filing at SEC.gov →

Microbot Medical receives first international regulatory approval for LIBERTY system in Israel

Microbot Medical announced that Israel's Ministry of Health AMAR Division approved marketing clearance for its LIBERTY Endovascular Robotic System, making Israel the second jurisdiction and first outside the U.S. to grant approval. The approval enables the company to obtain a Fre

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.